Anecdotes and tiny clinic case series cannot settle this. The studies that matter use national health registries, follow huge cohorts, and compare MMR recipients with children who never got the shot.
Madsen and colleagues did that in Denmark for the New England Journal of Medicine in 2002. They tracked 537,303 children born from 1991 through 1998. About 82% had received MMR. Autism was not more common in the vaccinated group. The relative risk for autistic disorder was 0.92 (95% CI 0.68 to 1.24). Age at vaccination and time since vaccination did not matter either.
Hviid and colleagues ran an even larger Danish cohort in 2019 (Annals of Internal Medicine): 657,461 children, 6,517 autism diagnoses. Fully adjusted hazard ratio for autism after MMR: 0.93 (95% CI 0.85 to 1.02). They also checked kids with an autistic sibling and kids with other autism risk factors. Still nothing. No clustering of new diagnoses in the window after vaccination either.
Then the pooling check. A 2014 meta-analysis in Vaccine combined five cohort studies covering more than 1.2 million children and five case-control studies with about 9,920 children. Vaccination was not associated with autism (cohort OR 0.99; 95% CI 0.92 to 1.06). MMR specifically wasn’t either (OR 0.84; 95% CI 0.70 to 1.01).
If MMR caused autism, you would expect higher rates after the shot, a louder signal in susceptible kids, or a spike right afterward. Those are exactly the patterns the large studies did not find.